Evaluation of Cardiovascular Disease Risk in HIV-1–Infected Patients Treated with Darunavir

INTRODUCTION: We evaluated cardiovascular disease (CVD) risk associated with darunavir treatment and examined the demographic/clinical characteristics of darunavir users based on data from Janssen-sponsored clinical trials, post-marketing pharmacovigilance databases, and administrative claims databa...

Descripción completa

Detalles Bibliográficos
Autores principales: Opsomer, Magda, Dimitrova, Dessislava, Verspeelt, Johan, Purrington, Amy, Mehbob, Abdul, Chavers, Scott, Pai, Helen, Vanveggel, Simon, Luo, Donghan, Brown, Kimberley, Moecklinghoff, Christiane, Nettles, Richard E., Boven, Katia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131121/
https://www.ncbi.nlm.nih.gov/pubmed/29992490
http://dx.doi.org/10.1007/s40268-018-0238-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131121/
https://www.ncbi.nlm.nih.gov/pubmed/29992490
http://dx.doi.org/10.1007/s40268-018-0238-8

Ejemplares similares